Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Yishen Formula (JPYSF) is a traditional Chinese medicine (TCM) herbal prescription widely used in China for the treatment of chronic kidney disease (CKD). It is a multi-herb decoction with a decades-long history of clinical use. The formula typically contains herbs such as Astragali Radix, Atractylodis Macrocephalae Rhizoma, Dioscoreae Rhizoma, Cistanches Herba, Amomi Fructus Rotundus, Salviae Miltiorrhizae Radix et Rhizoma, Rhei Radix et Rhizoma and Glycyrrhizae Radix et Rhizoma[8]. Mechanistically, JPYSF exerts renoprotective effects by modulating tryptophan metabolism and suppressing aryl hydrocarbon receptor signaling[1], enhancing sirtuin 3 expression to regulate mitochondrial dynamics and reduce oxidative stress[2], inhibiting inflammation via suppression of NF-κB signaling[3][5], restoring NAD+ homeostasis to alleviate renal fibrosis[4], and promoting antioxidant activity through Nrf2 pathway activation[5]. The formula has also been studied for its effects on immune modulation and macrophage polarization in CKD models[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Yishen Formula.